ConCallIQ
Go Pro
SBILIFE Diversified 01 Apr 2025

SBI Life Insurance Company Limited — Q4 FY25

SBI Life reported a strong Q4 FY25 with PAT up 27% to INR 24.13 billion, driven by improved product mix and margin expansion.

bullish high
Compare with...
Revenue
EBITDA
PAT ₹2,413 Cr +27%
EBITDA Margin
Duration
Read Time 1 min read

Financial stats pending filing verification

Risk Intelligence

Material risks this quarter

Concise cards keep the risk register scannable while preserving evidence-level context in the underlying quarter data.

Risks

R

Regulatory risk on bancassurance channel

Potential regulatory restrictions on bancassurance could impact a key distribution channel, though no formal discussions have occurred yet.

medium · analyst_question
R

Equity market volatility impacting ULIP demand

ULIP degrowth in Q4 was attributed to equity market volatility; continued weakness could affect growth and product mix targets.

medium · management_commentary
R

COVID cohort persistency risk

49-month persistency (COVID cohort) showed weakness, though management has taken revival measures and expects improvement.

low · management_commentary
R

Expense ratio increase from infrastructure investments

OpEx ratio increased from 4.9% to 5.3% due to branch expansion and hiring; further investments may pressure margins.

low · data_observation